Investment Rating - The report assigns a "Buy" rating for the company, marking its first coverage [4]. Core Insights - The company leverages its long-standing IPs in gaming and embraces AI to enhance efficiency and reduce costs, particularly in the MMORPG sector [2][36]. - The education segment, led by Mynd.ai, is transitioning towards a SaaS model, which is expected to improve profitability as the market for educational hardware enters a replacement cycle [3][55]. - Strategic investments in AI, AR, and the broader entertainment sector are aimed at building a long-term growth ecosystem [4][69]. Summary by Sections 1. Gaming and Application Services - The company has a strong foundation in MMORPGs, with flagship IPs like "Magic Domain," "Conquest," and "Spirit of Heroes" contributing to stable cash flow [36]. - AI integration has led to a 26.7% reduction in R&D costs in the gaming segment, enhancing profitability [51]. - The gaming segment is expected to generate revenues of 2,594 million, 3,160 million, and 3,318 million yuan from 2025 to 2027, with respective year-on-year growth rates of -25%, +7%, and +5% [76]. 2. Education Segment - Mynd.ai, a leader in educational interactive display devices, has a market share of nearly 16% in the global stock of interactive devices as of 2024 [3][56]. - The transition to a SaaS model is underway, with a 8% quarter-on-quarter growth in SaaS subscriptions, particularly for the flagship application "Explain Everything" [63]. - Revenue from the education segment is projected to be 1,685 million, 1,769 million, and 1,946 million yuan from 2025 to 2027, with year-on-year growth rates of -20%, +5%, and +10% [76]. 3. Strategic Investments - The company has made strategic investments in AI, AR, and the entertainment sector to create synergies with its core gaming and education businesses [4][69]. - Investments in companies like Rokid and Shuaiku Network are expected to enhance market competitiveness and provide new channels for user engagement [72][75]. - The collaboration with Zhongke Wenge aims to develop AI applications for various sectors, positioning the company as a leader in AI technology deployment [70].

Investment Rating - The report maintains an "Outperform" rating for the company with a target price of HKD 5.69, reflecting a 5.0% increase from the previous target price [2][7]. Core Insights - The company achieved a revenue of RMB 16.70 billion for FY9/25, representing a year-on-year growth of 17.0%. The gross profit margin improved to 25.1%, and the adjusted net profit increased by 38.7% to RMB 1.36 billion [3][14]. - The self-operated pharmaceutical business generated revenue of RMB 14.38 billion, growing by 18.6% year-on-year, driven by increases in pharmaceutical and medical device categories. The number of self-operated SKUs expanded significantly [18][14]. - The pharmaceutical e-commerce platform business reported revenue of RMB 1.84 billion, up 7.5% year-on-year, with improvements in operational capabilities and a significant increase in the number of merchants [18][14]. - The healthcare and digital services business generated revenue of RMB 480 million, reflecting an 8.2% year-on-year growth, with a notable increase in contracted healthcare professionals [18][14]. - The company has optimized its supply chain efficiency, with a reduction in fulfillment costs and an overall operating expense ratio of 18.3%, down 0.9 percentage points [15][14]. Financial Forecasts - Revenue forecasts for FY26 and FY27 are set at RMB 34.90 billion and RMB 39.38 billion, respectively, indicating year-on-year growth of 14.1% and 12.8% [16][7]. - Adjusted net profit forecasts for FY26 and FY27 are RMB 2.48 billion and RMB 2.83 billion, representing growth rates of 27.1% and 14.3% [16][7]. - The company's equity value is projected to be HKD 92.08 billion, corresponding to a share price of HKD 5.69 per share based on a DCF valuation [16][7].

Investment Rating - The report assigns a "Buy" rating for the company, marking its first coverage [1]. Core Insights - The company focuses on the development of optical imaging, fingerprint recognition modules, and automotive electronic components, aiming to enhance its product matrix and transition from a consumer electronics imaging solution provider to a core component supplier for smart hardware [6][15]. - The company is expected to benefit from optical innovation and the wave of automotive intelligence, leading to steady improvements in profitability and market share [15]. Summary by Sections Company Overview - The company is committed to the synergistic development of imaging and fingerprint recognition, focusing on high-end manufacturing upgrades [6][15]. - It aims to grow into a technology enterprise providing integrated machine vision and human vision solutions [15]. Mobile Camera Module Business - The company holds a leading global market share in mobile camera modules, with a focus on enhancing the structure of its products [7][27]. - The market for mobile camera modules is expected to continue its stable growth, driven by increasing smartphone penetration and consumption upgrades [30][32]. - The sales proportion of high-end mobile camera modules (32M pixels and above) reached 53.4% in the first half of 2025 [7][27]. Other Camera Module Business - The IoT and automotive camera markets are expanding rapidly, with the company seeing a 47.9% year-on-year growth in sales for these modules [8][36]. - The global automotive camera module market is projected to reach USD 27.3 billion by 2025, with the company aiming to replicate its mobile camera market position in this sector [8][36]. Fingerprint Recognition Module Business - The market for ultrasonic fingerprint recognition modules is gradually expanding, with significant improvements in sales and product structure leading to increased gross margins [9][46]. - The company reported that its sales of ultrasonic fingerprint recognition modules in the first half of 2025 exceeded the total sales for 2024 [9][48]. Financial Forecast and Investment Recommendation - Revenue projections for the company are estimated at RMB 20.447 billion, RMB 22.854 billion, and RMB 26.331 billion for 2025, 2026, and 2027, respectively, with corresponding net profits of RMB 714 million, RMB 909 million, and RMB 1.138 billion [10][12]. - The company's P/E ratios for the same years are expected to be 14.5x, 11.3x, and 9.1x, which are lower than the industry averages [10][12].

Investment Rating - The report assigns a "Buy" rating to the company, indicating a potential upside of 15% to 35% from the current price [5][10]. Core Insights - The company plans to repurchase up to approximately 104 million shares, which is about 9.7% of its total shares, signaling management's confidence in the company's future and belief that the stock is undervalued [6][7]. - The company has received its first Class III medical device certification for its recombinant type I α1 collagen product, marking its entry into the injectable aesthetic medicine market, which is expected to drive future growth [7]. - Despite recent stock price adjustments due to market conditions and lower-than-expected sales during the Double Eleven shopping festival, the report suggests that the stock has sufficiently adjusted and is poised for recovery [7]. Financial Projections - The company is projected to achieve net profits of RMB 2.43 billion, RMB 2.98 billion, and RMB 3.64 billion for the years 2025, 2026, and 2027, respectively, reflecting year-over-year growth rates of 17.8%, 22.5%, and 22.2% [9]. - Earnings per share (EPS) are expected to be RMB 2.27, RMB 2.78, and RMB 3.40 for the same years, with corresponding year-over-year growth rates of 8.1%, 22.5%, and 22.2% [9]. - The price-to-earnings (P/E) ratios are projected to decrease from 15x in 2025 to 10x in 2027, indicating a potential increase in value as the company grows [9]. Shareholder Information - The major shareholder is Fan Daidi, holding 55.13% of the shares, which indicates a strong control over the company [1]. - The company's market capitalization is approximately HKD 41.08 billion, with a current share price of HKD 36.58 [1]. Market Performance - The stock has experienced a significant decline, with a 24.4% drop over the past month and a 32.07% drop over the past three months [1]. - The stock price has fluctuated between a high of HKD 82.99 and a low of HKD 35.72 over the past year [1]. Product Portfolio - The company's product mix is heavily weighted towards functional skincare products, which account for 78.6% of total sales, while medical dressings contribute 23.3% and health products account for 0.3% [2].

Investment Rating - The report maintains a "Buy" rating for China Water Affairs (855 HK) with a target price adjusted to HKD 6.52, reflecting a potential upside of 10.1% from the current price of HKD 5.92 [5][8]. Core Insights - Despite a decline in overall revenue and net profit for FY26H1, the core water supply business showed resilience with a revenue increase of 4.5% and a sales volume increase of 5.0% [2][5]. - The company has accelerated its water price adjustments, with 8 projects approved for price increases, surpassing the annual target of 8 to 10 projects [3][5]. - A significant reduction in capital expenditure by 31.8% to HKD 12.4 billion in FY26H1 is expected to support the company's high dividend policy [4][5]. Financial Performance Summary - For FY26H1, total revenue and net profit decreased by 12.9% and 24.4% year-on-year, amounting to HKD 5.18 billion and HKD 570 million respectively [1][5]. - The water supply connection revenue fell by 28.6% to HKD 560 million, primarily due to fluctuations in the mainland real estate market [1][5]. - The wastewater treatment service revenue increased by 14.5% to HKD 360 million, driven by the Huizhou Mobil project contributing revenue since FY25 [2][5]. Revenue and Profit Forecast Adjustments - The forecast for shareholder net profit has been reduced by 10.8%, 14.8%, and 14.8% for FY26, FY27, and FY28 respectively [5][17]. - The target price adjustment reflects these changes, with the new estimates indicating a decrease in revenue projections for FY26 to HKD 9.899 billion, down from previous forecasts [5][17].

Investment Rating - The report does not explicitly state an investment rating for the company, but it suggests that the current macro environment continues to exert operational pressure on the company, indicating a cautious outlook on its performance [4]. Core Insights - The company reported a revenue decline of 5.4% year-on-year to HKD 4.036 billion for FY26H1, with adjusted EBITDA down 29.4% to HKD 243 million, and a net profit attributable to shareholders down 67.6% to HKD 46.7 million. The decline is attributed to weak restaurant performance in both Hong Kong and mainland China, as well as a normalization of consumer spending patterns [1][2]. - In response to the changing operational environment, the company is implementing significant business restructuring focused on six key areas: cost optimization, consolidation of advantageous business segments, restructuring of the fast-food segment, transformation of store models, integration of production lines, and exploring new business opportunities [3]. Summary by Relevant Sections Financial Performance - Revenue decreased by 5.4% year-on-year to HKD 4.036 billion, with specific declines in various segments: fast food (-5.9%), casual dining (-5.6%), institutional dining (-4.3%), and others (-8.1%). Mainland revenue fell by 3.8%. Net profit attributable to shareholders dropped by 67.6%, and when excluding fair value losses from investment properties, the decline was 59.4% [1][2]. Business Restructuring - The company is focusing on six main areas for restructuring: 1. **Cost Optimization**: Aiming for a 20% reduction in rental costs over the next three years and consolidating procurement for key ingredients to lower costs [3]. 2. **Strengthening Core Businesses**: Despite revenue impacts from closing inefficient stores, profitability in institutional and casual dining is improving [3]. 3. **Fast Food Segment Overhaul**: Addressing significant operational pressures by optimizing 220 fast-food outlets, particularly underperforming large and small stores [3]. 4. **Store Model Transformation**: Shifting focus from large stores to smaller models, with target sizes as low as 1,500 square feet to enhance operational flexibility [3]. 5. **Production Line Integration**: Strategically relocating production functions to mainland China to mitigate ongoing operational cost pressures in Hong Kong [3]. 6. **New Business Opportunities**: Actively seeking potential acquisition opportunities [3]. Investment Considerations - The ongoing macroeconomic changes are expected to continue impacting the company's operations, and while the restructuring efforts aim to restore confidence, a full recovery in performance is anticipated to take time. However, the high dividend yield (approximately 7% based on FY25 dividends) may provide some support for the stock price [4].

Charles Zhuang 庄怀超 SFC CE: BTE209 微信: zhuangcharles; 电话: (852) 9748 7114; 02 Dec 2025 环球富盛理财有限公司 紫金黄金国际 Zijin Gold International Company (2259.HK) 全球资源并购成绩优异，成本管控能力强大 Excellent performance in global resource mergers and acquisitions & Strong cost control capabilities 最新动态 ➢ 哈萨克斯坦斯坦 Raygorodok 金矿项目收购完成交割。紫金矿业控股子公司紫金黄金国际通过全资子公司收购哈萨克 斯坦斯坦 Raygorodok 金矿（RG 金矿）100%权益。鉴于协议中约定的交割先决条件已全部实现或豁免，本次收购已 于 2025 年 10 月 10 日完成交割，紫金黄金国际现已持有 RG 金矿 100%权益。根据紫金黄金国际招股说明书显示， 截至 2025 年 6 月 30 日，RG 金矿项目保有资源量：控制+推断级别矿石量 2.08 亿吨，金平均 ...

执业证书：S0600511080001 021-60199782 yuanl@dwzq.com.cn 证券研究报告·海外公司点评·公用事业Ⅱ(HS) 中国燃气（00384.HK） 2025/2026 财年中报点评：业绩承压，自由现 金流持续改善 买入（维持） | [Table_EPS] 盈利预测与估值 | FY2024A | FY2025A | FY2026E | FY2027E | FY2028E | | --- | --- | --- | --- | --- | --- | | 营业总收入（百万港元） | 81,410 | 79,258 | 76,748 | 77,444 | 78,489 | | 同比(%) | (11.50) | (2.64) | (3.17) | 0.91 | 1.35 | | 归母净利润（百万港元） | 3,185 | 3,252 | 2,976 | 3,182 | 3,446 | | 同比(%) | (25.82) | 2.09 | (8.47) | 6.92 | 8.30 | | EPS-最新摊薄（港元/股） | 0.58 | 0.60 | 0.55 | 0.58 | 0.63 ...

Investment Rating - The report assigns a "Buy" rating for the company, indicating a potential upside in the stock price [7][3]. Core Insights - The company reported a revenue of approximately RMB 15.2 billion for the first three quarters of 2025, representing a year-on-year increase of 23.7%. However, the net profit attributable to shareholders decreased by 25.7% to RMB 1.35 billion, while adjusted net profit increased by 6% to RMB 2.05 billion [8]. - In Q3, the company achieved a revenue of RMB 5.8 billion, a year-on-year increase of 28.2%, but the net profit attributable to shareholders fell by 31.4% to RMB 440 million. Adjusted net profit grew by 11.7% to RMB 770 million [8]. - The company’s gross margin for Q3 was 44.7%, a slight decline of 0.2 percentage points year-on-year. The overall expense ratio increased by 5.32 percentage points to 32.4% due to higher operating costs, particularly in direct store investments and marketing expenses [11]. - The company is expected to achieve net profits of RMB 1.93 billion, RMB 2.62 billion, and RMB 3.16 billion for the years 2025, 2026, and 2027, respectively, with corresponding EPS of RMB 1.56, RMB 2.12, and RMB 2.55 [11][13]. Summary by Relevant Sections Company Overview - The company operates primarily in the retail sector, with a market capitalization of approximately RMB 34.06 billion and a share price of HKD 38.54 as of December 1, 2025 [2]. Recent Performance - The company has shown a strong performance in its domestic and international operations, with notable revenue growth in both segments. The number of stores has increased significantly, with 4,407 stores in China and 3,424 stores overseas [11]. Financial Projections - The financial outlook indicates a decrease in net profit for 2025, followed by growth in subsequent years. The adjusted profit forecasts have been revised downwards due to the impact of acquisitions and operational costs [11][13]. Market Position - The company maintains a strong market position with a significant share of its revenue coming from its flagship brand, MINISO, which accounts for 90% of its product mix [4]. Valuation Metrics - The current price-to-earnings (P/E) ratios for the forecasted years are 22x for 2025, 17x for 2026, and 14x for 2027, indicating a favorable valuation compared to historical performance [13].

首次覆盖:定价首饰高增，加快海外拓展 六福集团(0590) 六福集团 FY2026 中报业绩点评 家庭及个人用品 [Table_Industry] 本报告导读： 定价首饰驱动同店销售持续改善，首次进驻越南市场。 投资要点： 金价上行及定价首饰占比提升驱动毛利率提升，费用率优化。 FY26H1 毛利率 34.7%/同比+2.0pct，受益金价上升及定价首饰占比提 升：FY26H1 克重黄金铂金销售额 40.96 亿港元/同比+11.0%，毛利率 30.3%/同比+2.8pct；定价首饰销售额 22.76 亿港元/同比+67.9%，毛 利率 36.8%/同比-0.5pct，冰钻等新品带动批发收入占比大幅增加。 其他亏损净额占收入 5.6%/同比+3.1pct，金价上涨导致黄金借贷未 变现亏损净额增加；销售费用率 16.3%/同比-1.5pct，行政费用率 2.7%/同比-0.8pct，受益经营杠杆。 风险提示：金价波动影响销量、开店不及预期、同店大幅下滑等。 | 财务摘要(百万港元) | FY2024 | FY2025 | FY2026E | FY2027E | FY2028E | | --- | --- | - ...